Itraconazole, voriconazole and natamycin 5% ophthalmic preparation proposed as WHO ‘essential antifungal medicines’

Posted by & filed under Uncategorized.

GAFFI has applied for itraconazole (capsules and oral suspension), voriconazole (capsules and intravenous solution) and natamycin 5% ophthalmic solution to be placed on the World Health Organization (WHO) Essential Medicine List (EML), in collaboration with colleagues from the Instituto de Salud Carlos III, International Foundation for Dermatology, London School of Hygiene of Tropical Medicine and… Read more »

550 AIDS patients can be saved every day by detecting and treating fungal infections

Posted by & filed under Uncategorized.

In 2013, 1,500,000 people died of AIDs according to the Joint United Nations Programme on HIV/AIDS (UNAIDS) report, and 3,000,000 HIV-infected people globally are at increased risk of acquiring a life-threatening fungal infection. Each year an estimated, 700 000 deaths (47%) due to fungal disease in AIDS were estimated – twice as many deaths as… Read more »